Grifols (GRFS) FCF Margin (2010 - 2019)
Grifols (GRFS) posted FCF Margin of 8.15% for Q1 2020, down 10.23% quarter-over-quarter from 9.08% in Q4 2019, and up 2265.0% year-on-year from 0.34% in Q2 2019.
Grifols (GRFS) FCF Margin (2010 - 2019) Analysis & Trends
Grifols (GRFS) has reported FCF Margin for 10 consecutive years, with 8.15% the latest figure, recorded in Q1 2020.
- FCF Margin for Q1 2020 came in at 8.15%, up 2265.0% year-over-year; the trailing twelve-month figure through Mar 2020 was 2.84% (down 324.0% YoY), and the FY2025 annual result was 10.39%, down 26437.0% from the prior year.
- FCF Margin was 8.15% for Q1 2020 at Grifols, down from 9.08% in the prior quarter.
- Over five years, FCF Margin peaked at 20.62% in Q2 2017 and troughed at 14.5% in Q1 2019.
- Average FCF Margin over 5 years is 10.94%, with a median of 12.52% recorded in 2018.
- Year-over-year, FCF Margin slumped 2356 bps in 2019 and surged 2265 bps in 2020.
- Over 5 years, FCF Margin stood at 9.24% in 2016, then surged by 90 bps to 17.56% in 2017, then declined by 29 bps to 12.52% in 2018, then dropped by 28 bps to 9.08% in 2019, then slipped by 10 bps to 8.15% in 2020.
- Per Business Quant data, the three most recent FCF Margin figures were 8.15% in Q1 2020, 9.08% in Q4 2019, and 14.5% in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 15.19% |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 6.09% |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 23.76% |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 3.80% |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 17.97% |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 17.14% |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 34.87% |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 93.16% |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 9.08% |
| Dec 31, 2018 | 12.52% |
| Dec 31, 2017 | 17.56% |
| Dec 31, 2016 | 9.24% |
| Dec 31, 2015 | 29.20% |
| Dec 31, 2014 | -26.86% |
| Dec 31, 2013 | 32.55% |
| Sep 30, 2013 | 12.84% |
| Jun 30, 2013 | 26.95% |
| Mar 31, 2013 | 13.51% |
| Dec 31, 2012 | 24.03% |
| Sep 30, 2012 | 20.79% |
| Jun 30, 2012 | 32.99% |
| Mar 31, 2012 | 0.01% |
| Dec 31, 2011 | 26.99% |
| Sep 30, 2011 | 7.76% |
| Jun 30, 2011 | -7.21% |
| Dec 31, 2010 | 12.86% |